Sign up to our newsletter Subscribe

OHE

Sign up to our newsletter Subscribe

Close
OHE
Newsletter SignupSubscribe

Biosimilars

Biosimilars have similar, but not identical, structures to branded biologic drugs. Being comparable, but not interchangeable, they can differ in cost-effectiveness and accessibility. Increased competition, however, can reduce healthcare system costs.

Featured

Filter results by

Theme
Select the product option you would like to filter Theme
Tag
Select the product option you would like to filter Tag
Date 1
Select the product option you would like to filter Date
Date From
Date To
Author
Select the product option you would like to filter Author
Content Type
Select the product option you would like to filter Content Type
Load More